International journal of pharmaceutics

turkish journal of chemistry

[1] Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

[2] Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.

[3] Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

[4] Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

[5] Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.

[6] Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler.

[7] Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.

[8] imagine the superiority of dry powder inhalers from carrier engineering

[9] influence of physical properties of carrier on the performance of dry powder inhalers